Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency

阅读量:

31

作者:

JM SchlossM ColosimoC AireyL Vitetta

展开

摘要:

Introduction Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a major concern for oncological practise considering the increasing number of cancer survivors and the lack of standardised prevention or treatment [ 1 ]. The incidence of CIPN depends on the chemotherapy agent administered but is estimated to occur in one third of all patients undergoing chemotherapy [ 2 , 3 ]. The prevalence of CIPN has been estimated to be 68.1% the first month after the administration of neurotoxic chemotherapy agents and 60% 3months post chemotherapy treatment. Patients were found to still have 30% prevalence 6months or more after chemotherapy according to the results published in a systematic review conducted in 2014 [ 4 ]. Patients experiencing moderate to severe CIPN report a reduced quality of life [ 5 ], chronic discomfort [ 6 ] and disruption of physical abilities for general life activities which can be temporary or permanent [ 5 ]. Currently in clinical practise, CIPN is assessed using th ...

展开

DOI:

10.1007/s00520-015-2725-6

被引量:

14

年份:

2015

通过文献互助平台发起求助,成功后即可免费获取论文全文。

我们已与文献出版商建立了直接购买合作。

你可以通过身份认证进行实名认证,认证成功后本次下载的费用将由您所在的图书馆支付

您可以直接购买此文献,1~5分钟即可下载全文,部分资源由于网络原因可能需要更长时间,请您耐心等待哦~

身份认证 全文购买

相似文献

参考文献

引证文献

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用